ã¡ãã£ã¢èšäº
æ°åãŠã€ã«ã¹ã®ããããããã«äŒŒãçç¶ãåå ã解æïŒä»ç 究
ããºãææ°ããŒã¯ 234
twitterã³ã¡ã³ã 60ä»¶äž 1ïœ60件
ã©ããªãã§ããããð€
ãããæ¥æ¬ããç¥ãããŠãªããããª
ç§ãç¥ããªãã£ããã©
ç§ãç¥ããªãã£ããã©
ãã£ïŒç§ãæšå¹Žããã³ã¬ãã£ãšæ²»ã£ãŠãŸãããïŒã¯ã¯ãã³æªæ¥çš®ã§ããïŒäœãããã®ãæ°ã«ãªãã®ã§ããïŒ
æããªããŠè¯ãäœè³ªã ãšå¬ãããâŠã
æããªããŠè¯ãäœè³ªã ãšå¬ãããâŠã
ãããªã£ãããCOVID-Toeã ã£ããã ãç¥ããªããã¡ã«éã£ãŠåã£ããã ãªâŠã
ã©ããã¢ã¬ã§ããã¢ã¬
ãžããã
ãã·ã§ã«ã»ãããŒããBBCãã¥ãŒã¹ãªã³ã©ã€ã³ä¿å¥ç·šéé·
ããããã«äŒŒãçç¶
æ°åã³ããã®ããããã«äŒŒãçç¶ç 究é²ãã§ã
åŸéºçã¯å€å²ã«æž¡ããŸãããããªãµãã«1ã€ãã€ã§ã解æãããŠãããšããã§ãã
æ¥æ¬ã§ãããã®ãïŒ
ã身äœããŠã€ã«ã¹ãæ»æããç¶æ
ã«åãæ¿ããéã®å¯äœçšãšã¿ããããšãããããã®ç¶æ
ãåŒãèµ·ããå
ç«ç³»ã®äžéšãç¹å®ããå¯ããšè¡æµã®åé¡ã§èµ·ãããããããšåæ§ïŒç¥ïŒå€§æµã®ã±ãŒã¹ã¯èªç¶ã«æ²»çãâ
ããããïŒãã®çç¶ãç§ã¯ã¯ã¯ãã³åŸã®æäœæ°å€ãç°æ§ã«é«ãã£ãããäœå
ã§ä»ãæŠã£ãŠããšããæããªãïŒ
åŸéºçã«æ©ãŸããŠãæ¹ã®èšäºãå€ããã©ãæäžãããè¬ã®å¯äœçšã®å¯èœæ§ã¯ãªãã®ããªãïŒ
ãããªããç¹ã«ãå ç«ã®æŽèµ°ã£ãŠè¬ã§çç¶ïŒå ç«ã®æ£åžžã®åå¿ïŒãæãããããªãå žåãããªãã®ïŒïŒ
ãããªããç¹ã«ãå ç«ã®æŽèµ°ã£ãŠè¬ã§çç¶ïŒå ç«ã®æ£åžžã®åå¿ïŒãæãããããªãå žåãããªãã®ïŒïŒ
ããã¯ã³ããæµè¡ãå§ããé ããããªãã®æ°ã®æ¹ããªã£ãŠããŸãããã
"å
ç«ç³»ã®2ã€ã®éšåãé¢ä¿ããŠãã ã²ãšã€ã¯ãã€ã³ã¿ãŒãã§ãã³IåããšåŒã°ããæãŠã€ã«ã¹ããã±ã質ãããã²ãšã€ã¯æäœã®äžçš®ã ãããã¡ãã¯äŸµå
¥ããŠãããŠã€ã«ã¹ã ãã§ãªããééããŠçŽ°èãçµç¹ãæ»æããŠããŸãã"
ã³ãã眹æ£åŸã«ã€ãŸå
ãæå
ã«ããããã®ãããªçç¶ãèµ·ããã±ãŒã¹ã«ã€ããŠããã©ã³ã¹ã®ç 究ããŒã ãåå ã解æãããš
> ãCOVIDã®ã€ãŸå ãã«ã¯å ç«ç³»ã®2ã€ã®éšåãé¢ä¿
> ã²ãšã€ã¯ãã€ã³ã¿ãŒãã§ãã³IåããšåŒã°ããæãŠã€ã«ã¹ããã±ã質ãããã²ãšã€ã¯æäœã®äžçš®
> ãCOVIDã®ã€ãŸå ãã«ã¯å ç«ç³»ã®2ã€ã®éšåãé¢ä¿
> ã²ãšã€ã¯ãã€ã³ã¿ãŒãã§ãã³IåããšåŒã°ããæãŠã€ã«ã¹ããã±ã質ãããã²ãšã€ã¯æäœã®äžçš®
ãCOVIDã®ã€ãŸå
ãã«ã¯å
ç«ç³»ã®2ã€ã®éšåãé¢ä¿ãã²ãšã€ã¯ãã€ã³ã¿ãŒãã§ãã³IåããšåŒã°ããæãŠã€ã«ã¹ããã±ã質ãããã²ãšã€ã¯æäœã®äžçš®ã ãã䟵å
¥ããŠãããŠã€ã«ã¹ã ãã§ãªããééããŠçŽ°èãçµç¹ãæ»æ
ãCOVIDã®ã€ãŸå
ããçºçããå Žåããããçºç±ãå³èŠãå
èŠã®ç°åžžãšãã£ãæ°åãŠã€ã«ã¹ã®å
žåçãªçç¶ã¯çŸããªãããšãå€ãã
å®ã¯å·Šæã®èŠªæãããã£ãœããªã£ãŠããšãããªãã ã
åºå
ãããããããŠæ°åã³ãããŠã€ã«ã¹æææ¡å€§åæã«èšãããè¡æ ãåè¢ã®å£æ»ã¿ãããªçç¶ãšãé¢é£ããŠããããŠ?
BBC:
ãããããããŠæ°åã³ãããŠã€ã«ã¹æææ¡å€§åæã«èšãããè¡æ ãåè¢ã®å£æ»ã¿ãããªçç¶ãšãé¢é£ããŠããããŠ?
BBC:
"ãCOVID ToeïŒCOVIDã®ã€ãŸå
ïŒããšåŒã°ããŠãããã®çç¶ã¯ã身äœããŠã€ã«ã¹ãæ»æããç¶æ
ã«åãæ¿ããéã®å¯äœçšãšã¿ããããšããã ã¯ã¯ãã³æ¥çš®åŸã¯ããŸãã"
æ°åã³ãããŠã€ã«ã¹ã«ããããããããã«äŒŒãçç¶ã«ã€ããŠBBCã®èšäºã玹ä»ããŸãã
ãCOVID ToeïŒCOVIDã®ã€ãŸå ïŒããšåŒã°ããç¹ã«åäŸã10代ã®è¥è ã«å€ããæåã¯çã¿ããªãå Žåãããããæ°Žã¶ãããè «ããèµ·ããã«ã€ããéåžžã«ããããªãããšãããããã§ãã
ãCOVID ToeïŒCOVIDã®ã€ãŸå ïŒããšåŒã°ããç¹ã«åäŸã10代ã®è¥è ã«å€ããæåã¯çã¿ããªãå Žåãããããæ°Žã¶ãããè «ããèµ·ããã«ã€ããéåžžã«ããããªãããšãããããã§ãã
æ¥çš®åŸ66æ¥ç®
ä»æ¥ã快調ã§ã
ãCOVIDã®ã€ãŸå ããšããã®ã¯åããŠç¥ããŸããã
ä»æ¥ã快調ã§ã
ãCOVIDã®ã€ãŸå ããšããã®ã¯åããŠç¥ããŸããã
# Yahooãã¥ãŒã¹
è¡æµé害ãããªãã£ãŠããšïŒïŒïŒ
ãã¯ããããããŸãã
ããããã¿ããã«ãªã£ãŠãããæ²»çãå¿ èŠãããšããèšäºã§ãã
ããããã¿ããã«ãªã£ãŠãããæ²»çãå¿ èŠãããšããèšäºã§ãã
ãããŒãããããïŒïŒæãâãïŒãããã£ããã©ããããã
åã©ãã«å€ãããããç¶ã®çç¶
å ç«ãæ£åžžçŽ°èãŸã§æ»æããŠããŸããšå€æ
å ç«ãæ£åžžçŽ°èãŸã§æ»æããŠããŸããšå€æ
MIS-Cãããã ãã©ãCovid-19ã¯æ¬åœã«å€æ§ãªçç¶ãåŒãããããªã
å»å¹Žã®2æé ã ã£ãã埮ç±ãšåŠæ æç¶ããæ(ä¿å¥æã«é£çµ¡ãããPCRæ€æ»ã§ãã2é±éèªå®
éé¢)ããããã®çç¶ãåºãã®ã§æ°åã³ããã«ææãããã ãª~ã£ãŠæã£ããçããçãããªãã
ãšãããä»å¹Žã®1æã«ãŸãããããçç¶ãåºããã ããæ¯å¬çç¶ç¶ãã®~ð€
ãšãããä»å¹Žã®1æã«ãŸãããããçç¶ãåºããã ããæ¯å¬çç¶ç¶ãã®~ð€
ãïŒä¿ºãæ°åã³ãã眹æ£å€æããçŽåãããã«è¶³ã®çªã®ç«¯ã«é
·ãã®ççèµ·ããŠãïŒ
å»è ãæçç©è³ªåºããŠããããããŠã£ã«ã¹ãšé¢ä¿ãªããšæã£ãŠããã©âŠ
å»è ãæçç©è³ªåºããŠããããããŠã£ã«ã¹ãšé¢ä¿ãªããšæã£ãŠããã©âŠ
ãCOVID ToeïŒCOVIDã®ã€ãŸå
ïŒã
COVIDã®ã€ãŸå
ãããããããïŒïŒïŒ
ã¯ã¯ãã³æã£ãåŸãŸãã«ä»ãããããè¬å¡ãããã£ãŠã»ãšãã©æ²»ã£ããã©ãŸã ç®èãããããŠçãã
ãããã§ãŠ2åç®ã®æåã§åºç¯å²ã«æ¹¿ç¹ð
ã¯ã¯ãã³æã£ãåŸãŸãã«ä»ãããããè¬å¡ãããã£ãŠã»ãšãã©æ²»ã£ããã©ãŸã ç®èãããããŠçãã
ãããã§ãŠ2åç®ã®æåã§åºç¯å²ã«æ¹¿ç¹ð
ã³ããã¯ã¯ãã³æã£ãŠïŒãïŒé±éçµã£ãŠãããããªé¢šãªçç¶ãåºããã ãããã ã£ãã®ããªã
ã§ãããã¯ã¯ãã³æ¥çš®åŸã«ãã®çç¶ãåºãããšã¯ããã«ãŸãã ããšæžããŠããããªãã
ãã ãã
ã§ãããã¯ã¯ãã³æ¥çš®åŸã«ãã®çç¶ãåºãããšã¯ããã«ãŸãã ããšæžããŠããããªãã
ãã ãã
ããããïŒ
ããCOVID ToeïŒCOVIDã®ã€ãŸå
ïŒããšåŒã°ããŠãããã®çç¶ã¯ã身äœããŠã€ã«ã¹ãæ»æããç¶æ
ã«åãæ¿ããéã®å¯äœçšãšã¿ããããšããã
身äœããŠã€ã«ã¹ãæ»æããç¶æ
ã«åãæ¿ããéã®å¯äœçš
å ç«ç³»ã®2ã€ã®éšåãé¢ä¿
ã»æãŠã€ã«ã¹ããã±ã質ãã€ã³ã¿ãŒãã§ãã³Iåã
ã»æäœã®äžçš®
ã©ã¡ãããäœããŠã€ã«ã¹ãšéãéã«äœ¿ãããæ©èœ
å ç«ç³»ã®2ã€ã®éšåãé¢ä¿
ã»æãŠã€ã«ã¹ããã±ã質ãã€ã³ã¿ãŒãã§ãã³Iåã
ã»æäœã®äžçš®
ã©ã¡ãããäœããŠã€ã«ã¹ãšéãéã«äœ¿ãããæ©èœ
ãªãã»ã©ð€ãªãã»ã©ð€
ãããªã®ã
ãããªã®ã
ãCOVID ToeïŒCOVIDã®ã€ãŸå
ïŒããšåŒã°ããŠãããã®çç¶ã¯ã身äœããŠã€ã«ã¹ãæ»æããç¶æ
ã«åãæ¿ããéã®å¯äœçšãšã¿ãããã
ãCOVID ToeïŒCOVIDã®ã€ãŸå
ïŒããšåŒã°ããŠãããã®çç¶ã¯ã身äœããŠã€ã«ã¹ãæ»æããç¶æ
ã«åãæ¿ããéã®å¯äœçšãšã¿ããããšããã
â
次ãã次ãžãš...ððð¥
â
次ãã次ãžãš...ððð¥
ãã©ãã®æ足ã®ç¶æ
ã«ã泚æããªããã
"ãã¯ã¯ãã³æ¥çš®åŸã«ãã®çç¶ãåºãããšã¯ããã«ãŸãã ã çŸåšçåšãæ¯ãã£ãŠãããã«ã¿æ ªã®æµè¡ã§ã¯å°ãªããªã£ãŠãã"/æ±ç±æã¡ãšããŠã¯å®å¿ã§ããæ
å ±
COVID-19ã§ãã€ãŸå
ãæå
ã«ããããã®ãããªçç¶ãèµ·ããã±ãŒã¹ã«ã€ããŠããã©ã³ã¹ã®ç 究ããŒã ãåå ã解æããã
ãCOVID ToeïŒCOVIDã®ã€ãŸå ïŒããšåŒã°ããŠãããã®çç¶ã¯ã身äœããŠã€ã«ã¹ã
ãCOVID ToeïŒCOVIDã®ã€ãŸå ïŒããšåŒã°ããŠãããã®çç¶ã¯ã身äœããŠã€ã«ã¹ã
ãCOVIDã®ã€ãŸå
ãïŒð€
ã³ããææã®åå¿ã§ã€ãŸå
ãæå
ã«åºãçŽ
æãå€è²ã®åå ãããã£ããããããèŠããã§ãæ¹æå€ãšå€ãã¿ãããèãããã èšäºäžã«æžãããŠãããè¿ãŸã§åºã人ãå±
ããã ããè¬æ¬²ãããããã
ïŒ ïŒãCOVID ToeïŒCOVIDã®ã€ãŸå
ïŒããšåŒã°ããŠãããã®çç¶ã¯ã身äœããŠã€ã«ã¹ãæ»æããç¶æ
ã«åãæ¿ããéã®å¯äœçšãšâŠ
ããªå€§åŠã®ç 究ããŒã ã¯ãæ°åã³ããææçã§COVID ToeãšåŒã°ãããã€ãŸå
ãæå
ã«ããããã«äŒŒãçç¶ãèµ·ããã±ãŒã¹ã«ã€ããŠãåå ã解æããããã®çç¶ã¯èº«äœããŠã€ã«ã¹ãæ»æããéã®å¯äœçšãšã¿ãããã€ã³ã¿ãŒãã§ãã³Iå æãŠã€ã«ã¹ã¿ã³ãã¯è³ªãšæäœã®äžçš®ãåå ãšããã
British Journal of Dermatology - Wiley Online Library
ããã2020幎ã®æ£æã«ãªã£ããã ããªâŠâŠã
ãžãŒãŒãŒãŒçç¶èªäœå
šç¶ç¥ãããã£ãã -
COVID Toe ãšããçç¶ããããããã
â«æ°åãŠã€ã«ã¹ã®ããããããã«äŒŒãçç¶
åå ã解æïŒä»ç 究
â«ã¯ã¯ãã³æ¥çš®åŸã¯ããŸãã
â«ããã¯å€ãã®äººãã¯ã¯ãã³ãªã©äžå®ã®äºé²çãè¬ããããã«ãªã£ããã
çµå±ðã®å®£äŒèšäºã ã
å¯åå¿ã¯ãâããããâ ããæžãŸãªãããããªãã ãã©..
æãããããŠå¿ æ»ã ãªð
åå ã解æïŒä»ç 究
â«ã¯ã¯ãã³æ¥çš®åŸã¯ããŸãã
â«ããã¯å€ãã®äººãã¯ã¯ãã³ãªã©äžå®ã®äºé²çãè¬ããããã«ãªã£ããã
çµå±ðã®å®£äŒèšäºã ã
å¯åå¿ã¯ãâããããâ ããæžãŸãªãããããªãã ãã©..
æãããããŠå¿ æ»ã ãªð
ç§ã®æ足æå
ã®ããããã¶ã€ã¶ã€ã¯ããããšåãã§ãã¯ã¯ãã³ã®å¯åå¿ã ãšæã£ãŠã
çšã£ãŠæžããŠãããã©ãåããããªäººãTwitterã§ã¡ãã£ãšæ€çŽ¢ããã ãã§ãã¡ããã¡ããèŠãããããŒ
çšã£ãŠæžããŠãããã©ãåããããªäººãTwitterã§ã¡ãã£ãšæ€çŽ¢ããã ãã§ãã¡ããã¡ããèŠãããããŒ
è¡æ ããšæã£ããå
ç«åå¿
ãªãããããïŒè¡ç®¡å
ç®ãªãå
匵ãããŠãããšèšããã®ã ãïŒè¡ç®¡åšç®çŽ°èãšèšãããã®ããªïŒ
æ¯çŽ°è¡ç®¡ã«äžŠãã§ãã现èãé¢ä¿ããŠãããšããã
æ¯çŽ°è¡ç®¡ã«äžŠãã§ãã现èãé¢ä¿ããŠãããšããã
åè²ãŠå¢ã§ã¯ç颚ïŒãªãŠããïŒãŠãªã£ãŠããã©ããã®å¢ã ãšã®ã£ãŒæ¢
æ¯ïŒãŠãªããã
ã¯ã¯ãã³ïŒåç®æ¥çš®åŸã身äœã®ãã¡ãã¡ã«æ¹¿ç¹ãã§ããŠãããã£ããã§ããã©ããããã ã£ãã®ããªã
身äœãæ»ææ å¢ã«åãæ¿ãã£ã蚌æ ã ãããæªãããšã§ã¯ãªããã ãã©ãã¢ã¬ã«ã®ãŒãšåºå¥ã€ããªããŠæ©ãã§ã(ç¬)
ã¢ãã«ãã¢ãŒã ãºã®çç¶ãæ¶ããããã¿ãªãšåãŸããŸããã
身äœãæ»ææ å¢ã«åãæ¿ãã£ã蚌æ ã ãããæªãããšã§ã¯ãªããã ãã©ãã¢ã¬ã«ã®ãŒãšåºå¥ã€ããªããŠæ©ãã§ã(ç¬)
ã¢ãã«ãã¢ãŒã ãºã®çç¶ãæ¶ããããã¿ãªãšåãŸããŸããã
ããããããã«äŒŒãæ°åã³ãããŠã€ã«ã¹ã®çç¶ãã€ãŸå
ã«åºãããšãããããã§ãã